A randomised controlled trial of acceptance and commitment therapy (ACT) for psychosis: Study protocol

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Thomas, Neil ^a,b   Shawyer, Frances ^c,d   Castle, David J ^e,f   Copolov, David ^c,e,g   Hayes, Steven C ^h   Farhall, John ^d,i  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b Australia   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f ST VINCENT S HOSPITAL   (Australia)

^g FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^h UNIVERSITY OF NEVADA   (United States)

ⁱ NorthWestern Mental Health   (Australia)

Author keywords

Acceptance and commitment therapy (ACT); Auditory hallucinations; Befriending; Delusions; Negative symptoms; Positive symptoms; Psychological therapy; Psychosis; Randomised controlled trial (RCT); Schizophrenia

Indexed keywords

ACCEPTANCE AND COMMITMENT THERAPY; ADAPTIVE BEHAVIOR; ADULT; AGED; ARTICLE; AUDITORY HALLUCINATION; BEFRIENDING; BRIEF PSYCHIATRIC RATING SCALE; COGNITION; COGNITIVE THERAPY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DELUSION; DISABILITY; DISTRESS SYNDROME; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MENTAL HEALTH; MENTAL HEALTH SERVICE; MULTICENTER STUDY; PALLIATIVE THERAPY; POSITIVE AND NEGATIVE SYNDROME SCALE; PROSPECTIVE STUDY; PSYCHOSIS; PSYCHOTIC SYMPTOM RATING SCALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SELF REPORT; SEMI STRUCTURED INTERVIEW; SINGLE BLIND PROCEDURE; SOCIAL INTERACTION; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; VERBAL MEMORY; AUSTRALIA; DELUSIONS; FEMALE; HALLUCINATIONS; MALE; NEW ZEALAND; PATIENT SELECTION; PSYCHOTIC DISORDERS; SAMPLE SIZE; ASSESSMENT OF HUMANS; DSM-IV-TR; HALLUCINATION; INTELLIGENCE QUOTIENT; OUTCOME ASSESSMENT; TREATMENT DURATION; WECHSLER INTELLIGENCE SCALE;

NEUROLEPTIC AGENT; CHLORPROMAZINE;

ACCEPTANCE AND COMMITMENT THERAPY; ANTIPSYCHOTIC AGENTS; AUSTRALIA; DELUSIONS; FEMALE; HALLUCINATIONS; HUMANS; MALE; NEW ZEALAND; PATIENT SELECTION; PSYCHOTIC DISORDERS; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 84904078909     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-14-198     Document Type: Article

References (84)

1. Dickerson FB, Lehman AF. Evidence-based psychotherapy for schizophrenia. J Nerv Ment Dis 2006, 194(1):3-9.
2. Morrison AP, Barratt S. What are the components of CBT for psychosis? A Delphi study. Schizophr Bull 2010, 36(1):136-142.
3. Gaudiano BA. Cognitive Behavior Therapies for Psychotic Disorders: Current Empirical Status and Future Directions. Clin Psychol Sci Pr 2005, 12(1):33-50.
4. Chadwick P, Birchwood M, Trower P. Cognitive Therapy for Delusions, Voices and Paranoia 1996, Chichester: John Wiley & Sons.
5. Garety P, Fowler D, Kuipers E. Cognitive-Behavioral Therapy for medication-resistant symptoms. Schizophr Bull 2000, 26(1):73-86.
6. Gould RA, Mueser KT, Bolton E, Mays V, Goff D. Cognitive therapy for psychosis in schizophrenia: an effect size analysis. Schizophr Res 2001, 48:335-342.
7. Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Orbach G, Morgan C. Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med 2002, 32:763-782.
8. Rector N, Beck AT. Cognitive behavioral therapy for schizophrenia: an empirical review. J Nerv Ment Dis 2001, 189:278-287.
9. Jones C, Cormac I, Silveira-da-Mota-Neto JI, Campbell C. Cognitive behaviour therapy for schizophrenia. Cochrane Database Syst Rev 2004, 4:CD000524. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000524.pub2/pdf.
10. National Institute for Clinical Excellence Schizophrenia 2002, London: NICE, National Institute for Clinical Excellence.
11. National Institute for Clinical Excellence Psychosis and Schizophrenia in Adults: Treatment and Management 2014, London: NICE, National Institute for Clinical Excellence.
12. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines team for the treatment of schizophrenia and related disorders Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust NZ J Psychiat 2005, 39(1-2):1-30. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines team for the treatment of schizophrenia and related disorders.
13. Tarrier N, Wykes T. Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale?. Behav Res Ther 2004, 42:1377-1401.
14. Jauhar S, McKenna PJ, Radua J, Fung E, Salvador R, Laws KR. Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Brit J Psychiat 2014, 204(1):20-29.
15. Lynch D, Laws KR, McKenna PJ. Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled studies. Psychol Med 2010, 40:9-24.
16. Jones C, Hacker D, Cormac I, Meaden A, Irving CB. Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. Cochrane Database Syst Rev 2012, 4:CD008712. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008712.pub2/pdf.
17. Jones C, Hacker D, Cormac I, Meaden A, Irving CB. Cognitive Behavior Therapy Versus Other Psychosocial Treatments for Schizophrenia. Schizophr Bull 2012, 38(5):908-910.
18. Birchwood MJ, Shiers D, Smith J. CBT for psychosis: not a quasi-neuroleptic. Brit J Psychiat 2014, http://bjp.rcpsych.org/content/204/1/20/reply#bjprcpsych_el_55218.
19. Byrne RE. RE: Cognitive-behavioural therapy for the symptoms of schizophrenia. Brit J Psychiat 2014, http://bjp.rcpsych.org/content/204/1/20/reply#bjprcpsych_el_55218.
20. Chadwick P, Lowe CF. Measurement and modification of delusional beliefs. J Consult Clin Psych 1990, 58(2):225-232.
21. Garety P, Fowler D, Kuipers E, Freeman D, Dunn G, Bebbington P, Hadley C, Jones S. London-East Anglia randomized controlled trial of cognitive-behavioural therapy for psychosis. II: Predictors of outcome. Brit J Psychiat 1997, 171:420-426.
22. McGowan JF, Lavender T, Garety P. Factors in outcome of cognitive-behavioural therapy for psychosis: Users' and clinicians' views. Psychol Psychother Theor Res Pract 2005, 78:513-529.
23. Cather C, Penn D, Otto M, Goff D. Cognitive therapy for delusions in schizophrenia: models, benefits, and new approaches. J Cognit Psychother 2004, 18(3):207-221.
24. Brehm JW. A Theory of Psychological Reactance 1966, New York: Academic Press.
25. Milton F, Patwa VK, Hafner RJ. Confrontation vs belief modification in persistently deluded patients. Brit J Med Psychol 1978, 51:127-130.
26. Turkington D, Kingdon D, Turner T. Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. Brit J Psychiat 2002, 180:523-527.
27. Wykes T, Hayward P, Thomas N, Green N, Surguladze S, Fannon D, Landau S. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophr Res 2005, 77(2-3):201-210.
28. Durham RC, Guthrie M, Morton RV, Reid D, Treliving LR, Fowler D, MacDonald RR. Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Brit J Psychiat 2003, 182:303-311.
29. Hayes SC, Strosahl KD, Wilson KG. Acceptance and Commitment Therapy: An Experiential Approach to Behavior Change 1999, New York: The Guilford Press.
30. Hayes SC, Strosahl KD, Wilson KG. Acceptance and Commitment Therapy: An Experiential Approach to Behavior Change 2013, New York: The Guilford Press, 2.
31. Barnes-Holmes Y, Hayes SC, Barnes-Holmes D, Roche B. Relational frame theory: A post-Skinnerian account of human language and cognition. Advances in Child Development and Behavior 2001, 101-138. San Diego, CA: Academic Press, Reese HW, Robert K.
32. Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther 2006, 44(1):1-25.
33. Hayes SC. Acceptance and Commitment Therapy, Relational Frame Theory, and the third wave of behavior therapy. Behav Ther 2004, 35(4):639-665.
34. Bach P, Hayes SC. The use of Acceptance and Commitment Therapy to prevent rehospitalization of psychotic patients: a randomized controlled trial. J Consult Clin Psych 2002, 70(5):1129-1139.
35. Turkington D, Dudley R, Warman DM, Beck AT. Cognitive-behavioural therapy for schizophrenia: a review. J Psychiat Prac 2004, 10(1):5-16.
36. Gaudiano BA, Herbert JD. Acute treatment of inpatients with psychotic symptoms using Acceptance and Commitment Therapy: pilot results. Behav Res Ther 2006, 44:415-437.
37. Bach P, Gaudiano BA, Hayes SC, Herbert JD. Acceptance and commitment therapy for psychosis: intent to treat, hospitalization outcome and mediation by believability. Psychosis 2013, 5(2):166-174.
38. Shawyer F, Farhall J, Mackinnon A, Trauer T, Sims E, Ratcliff R, Larner C, Thomas N, Castle D, Mullen P, Copolov D. A randomised controlled trial of acceptance-based cognitive behavioural therapy for command hallucinations in psychotic disorders. Behav Res Ther 2012, 50:110-121.
39. Shawyer F, Farhall J. Acceptance-based CBT for command hallucinations: rationale, implementation, outcomes and reflections from the TORCH project. Acceptance and Mindfulness in the Treatment of Psychosis: Current Trends and Future Directions New York: Oxford University Press, Gaudiano BA, in press.
40. Brett-Jones J, Garety PA, Hemsley D. Measuring delusional experiences: a method and its application. Brit J Clin Psychol 1987, 26:257-265.
41. Haddock G, McCarron J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the psychotic rating scale (PSYRATS). Psychol Med 1999, 29:879-889.
42. Peters E, Day S, McKenna J, Orbach G. Delusional ideation in religious and psychotic populations. Br J Clin Psychol 1999, 38(Pt 1):83-96.
43. Peters E, Joseph S, Day S, Garety P. Measuring delusional ideation: the 21-item Peters et al. Delusions Inventory (PDI). Schizophr Bull 2004, 30(4):1005-1022.
44. Singer AR, Dobson KS. An experimental investigation of the cognitive vulnerability to depression. Behav Res Ther 2007, 45(3):563-575.
45. Thomas N. A model for the development of acceptance and mindfulness based therapies: Preoccupation with psychotic experiences as a treatment target. Acceptance and Mindfulness in the Treatment of Psychosis: Current Trends and Future Directions New York: Oxford University Press, Gaudiano BA, in press.
46. Farhall J, Greenwood KM, Jackson HJ. Coping with hallucinated voices in schizophrenia: a review of self-initiated strategies and therapeutic interventions. Clin Psychol Rev 2007, 27(4):476-493.
47. Shawyer F, Farhall J, Sims EF, Copolov D. Command hallucinations in psychosis: acceptance and disengagement as a focus of treatment. Theory and Practice in Contemporary Australian Cognitive and Behaviour Therapy: Proceedings of the 28th National AACBT Conference 2005, 5-14. Melbourne: Australian Association for Cognitive Behaviour Therapy, Jackson M, Murphy G.
48. Gaudiano BA, Herbert JD. Believability of Hallucinations as a Potential Mediator of Their Frequency and Associated Distress in Psychotic Inpatients. Behav Cogn Psychoth 2006, 34(04):497-502.
49. McGlashan TH, Levy ST, Carpenter WT. Integration and sealing over: clinically distinct recovery styles from schizophrenia. Arch Gen Psychiat 1975, 32:1269-1272.
50. White R, Gumley A, McTaggart J, Rattrie L, McConville D, Cleare S, Mitchell G. A feasibility study of Acceptance and Commitment Therapy for emotional dysfunction following psychosis. Behav Res Ther 2011, 49(12):901-907.
51. Caspi A, Reichenberg A, Weiser M, Rabinowitz J, Kaplan Z, Knobler H, Davidson-Sagi N, Davidson M. Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. Schizophr Res 2003, 65(2-3):87-94.
52. Fioravanti M, Bianchi V, Cinti M. Cognitive deficits in schizophrenia: an updated metanalysis of the scientific evidence. BMC Psychiatry 2012, 12(1):64.
53. Tandon R, Keshavan M, Nasrallah H. Schizophrenia, " Just the Facts" : What we know in 2008 Part 1: Overview. Schizophr Res 2008, 100(1-3):4-19.
54. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Patient Edition (SCID-I/P, 1/2007 revision) 2007, New York, New York: Biometrics Research Department, New York State Psychiatric Institute.
55. Kay SR. Positive and Negative Syndromes in Schizophrenia 1991, New York: Brunner/Mazel.
56. Wechsler D. Wechsler Test of Adult Reading 2001, New York: Psychological Corporation.
57. Bach PA. ACT with the seriously mentally ill. A Practical Guide to Acceptance and Commitment Therapy 2005, New York: Springer, Hayes SC, Strosahl KD.
58. Bendall S, Killackey E, Jackson HJ, Gleeson J. Befriending Manual 2003, Melbourne: ORYGEN Research Centre, University of Melbourne.
59. Sensky T, Turkington D, Kingdon D, Scott JL, Scott J, Siddle R, O'Carroll M, Barnes TRE. A randomized controlled trial of cognitive-behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Arch Gen Psychiat 2000, 57(2):165-172.
60. Bendall S, Jackson HJ, Killackey E, Allot K, Johnson T, Harrigan S, Gleeson J, McGorry PD. The credibility and acceptability of Befriending as a control therapy in a randomized controlled trial of Cognitive Behaviour Therapy for acute first episode psychosis. Behav Cog Psychoth 2006, 34:277-291.
61. Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiat 1990, 157:853-859.
62. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharm 1996, 11(Suppl 3):89-95.
63. Jolley S, Garety PA, Ellett L, Kuipers E, Freeman D, Bebbington PE, Fowler DG, Dunn G. A validation of a new measure of activity in psychosis. Schizophr Res 2006, 85(1-3):288-295.
64. Gumley A, O'Grady M, McNay L, Reilly J, Power K, Norrie J. Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychol Med 2003, 33(3):419-431.
65. Hayes SC, Strosahl KD, Wilson KG, Bissett RT, Pistorello J, Toarmino D, Polusny M,A, Dykstra TA, Batten SV, Bergan J, Stewart SH, Zvolensky MJ, Eifert GH, Bond FW, Forsyth JP, Karekla M, McCurry SM. Measuring experiential avoidance: a preliminary test of a working model. Psychol Rec 2004, 54(4):553-578.
66. Bond FW, Hayes SC, Baer RA, Carpenter KM, Guenole N, Orcutt HK, Waltz T, Zettle RD. Preliminary psychometric properties of the Acceptance and Action Questionnaire-II: a revised measure of psychological inflexibility and experiential avoidance. Behav Ther 2011, 42(4):676-688.
67. Shawyer F, Ratcliff R, Mackinnon A, Farhall J, Hayes SC, Copolov D. The Voices Acceptance and Action Scale (VAAS): pilot data. J Clin Psychol 2007, 63(6):593-606.
68. Drayton M, Birchwood M, Trower P. Early attachment experience and recovery from psychosis. Br J Clin Psychol 1998, 37(Pt 3):269-284.
69. McGlashan TH. Recovery style from mental illness and long-term outcome. J Nerv Ment Dis 1987, 175(11):681-685.
70. Wechsler D. Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) 1997, San Antonio: The Psychological Corporation.
71. Randolf C. Repeatable Battery for the Assessment of Neuropsychological Status 1998, San Antonio: The Psychological Corporation.
72. Randolf C. Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Supplement 1 2006, Harcourt Assessment, http://images.pearsonclinical.com/images/PDF/technical_reports/RBANS.pdf.
73. Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiat 2010, 167(6):686-693.
74. Attkisson CC, Zwick R. The Client Satisfaction Questionnaire: psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann 1982, 5(3):233-237.
75. Gueorguieva R, Krystal JH. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiat 2004, 61(3):310-317.
76. Sheiner LB, Rubin DB. Intention-to-treat analysis and the goals of clinical trials. Clin Pharmacol Ther 1995, 57(1):6-15.
77. Houck PR, Mazumdar S, Koru-Sengul T, Tang G, Mulsant BH, Pollock BG, Reynolds CF. Estimating treatment effects from longitudinal clinical trial data with missing values: comparative analyses using different methods. Psychiat Res 2004, 129(2):209-215.
78. Bruce ML, Ten Have TR, Reynolds CF, Katz II, Schulberg HC, Mulsant BH, Brown GK, McAvay GJ, Pearson JL, Alexopoulos GS. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA 2004, 291(9):1081-1091.
79. Sobel ME. Asymptotic confidence intervals for indirect effects in structural equations models. Sociol Methodol 1982, 13:290-312.
80. MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods 2002, 7(1):83-104.
81. Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput 2004, 36(4):717-731.
82. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008, 40(3):879-891.
83. Ost LG. Efficacy of the third wave of behavioral therapies: a systematic review and meta-analysis. Behav Res Ther 2008, 46:296-321.
84. Wykes T, Steel C, Everitt B, Tarrier N. Cognitive Behavior Therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull 2008, 34(3):523-537.